E-mail:gzliang@cqu.edu.cn    Tel: (86)2365102507

List of peptide properties
DFBP ID - DFBPOPIO0008(Opioid peptide)
DFBP ID DFBPOPIO0008
Peptide sequence RYLGYL
Type Native peptide
Peptide/Function name Opioid peptide, Exorphin, Exomorphin, α-Casein exorphin [3]
Function-activity relationship
Main bioactivity Opioid activity
Otheir bioactivity N.D
Calculated physicochemical properties
Three-letter amino acid Arg-Tyr-Leu-Gly-Tyr-Leu
Single-letter amino acid RYLGYL
Peptide length 6
Peptide mass
Experimental mass Theoretical mass
N.D 783.91 Da c
Net charge 0.00 c
Isoelectric point (pI) 9.59 c
IC50 N.D
pIC50 N.D
GRAVY 0.0167 c
Hydrophilic residue ratio 50% c
Peptide calculator
To calculate the physicochemical properties of bioactive peptide.
Peptide source & Food-borne protein(s) search
Classification Animal
Organism/Source Bovine milk protien
Precursor protein αs1-Casein
Residue position f(90-95)
Precursor protein(s) search
Link-research
There are no literature reports on the discovery of this sequence in other food-source proteins.
Biological/Functional activity & target protein
Opioid activity The peptide RYLGYL was specific ligands for the u- and δ-receptor. It showed opioid activity as measured by several standard assay procedures. Whereas RYLGYL exhibits a somewhat weaker but still substantial affinity. As shown in table 1.
Table 1 Opioid activity of peptide
Peptide
Opiate assay (IC50, uM)/Activity
Displacement of [3H]DALAMID from rat brain membranes
Displacement of [3H]DHM from rat brain membranes
Inhibition of adenylate cyclase in homogenates of NG108-15 cells
Inhibition of electrically stimulated mouse vas deferens
Isolated α-casein exorphin a
3.8
0.3
11.0
RYLGYL3.6
12.0
2.0
70.0
Opioid agonist [3]
a Opioid peptides from pepsin hydrolysates of α-casein.
Specific target protein(s) Specific Target Protein(s):
Mu-type opioid receptor
Delta-type opioid receptor
Taste properties & Structure
Bitterness
Literature report N.D
Bitter prediction tools Bitter taste prediction
SMILES N[C@@]([H])(CCCNC(=N)N)C(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CC(C)C)C(=O)NCC(=O)N[C@@]([H])(Cc1ccc(O)cc1)C(=O)N[C@@]([H])(CC(C)C)C(=O)O
Preparation method
Mode of preparation Enzymatic hydrolysis
Enzyme(s)/starter culture

Hydrolysis with Pepsin.

Stability & Cytotoxicity
Peptide stability
Literature report:

The peptide was resistant to hydrolysis by trypsin and homogenates of rat brain membranes, but was partially inactivated by chymotrypsin and subtilisin.

EHP-Tool: Enzymatic Hydrolysis Prediction Tool (EHP-Tool)
Peptide cytotoxicity
Literature report: N.D
Prediction: ToxinPred
Additional information
Additional information N.D
Database cross-references
BIOPEP-UWM [D1] 3128, 9620
APD [D2] -
BioPepDB [D3] -
MBPDB [D4] -
Reference(s)
Primary literature Loukas S, Varoucha D, Zioudrou C, Streaty RA, Klee WA. Opioid activities and structures of alpha-casein-derived exorphins. Biochemistry. 1983 Sep 13;22(19):4567-73.
PMID: 6313043
Other literature(s)

[1] Park Y W. Bioactive Components in Milk and Dairy Products[M]. 2009.
[2] Migliore-Samour D, Floc'H F, Jollès P. Biologically active casein peptides implicated in immunomodulation[J]. Journal of Dairy Research, 1989, 56(3):357.
[3] Kostyra E, Sienkiewiczszłapka E, Jarmołowska B, et al. Opioid peptides derived from milk proteins.[J]. Polish Journal of Food & Nutrition Sciences, 2004.
[4] Yoshikawa M., Tani F., Yoshimura T., Chyba H., Opioid peptides from milk proteins. Agric. Biol. Chem., 1986, 50, 2419–2421.
[5] Meisel H. Overview on Milk Protein-derived Peptides[J]. International Dairy Journal, 1998, 8(5–6):363-373.
[6] Fiat A M, Jollès P. Caseins of various origins and biologically active casein peptides and oligosaccharides: Structural and physiological aspects[J]. Molecular & Cellular Biochemistry, 1989, 87(1):5-30.
[7] Schlimme E, Meisel H. Bioactive peptides derived from milk proteins. Structural, physiological and analytical aspects.[J]. Nahrung, 1995, 39(1):1-20.

PubDate 1983
Copyright © 2020. Record / license number: Chongqing ICP No. 2000214